UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (12) 12
life sciences & biomedicine (10) 10
science & technology (10) 10
humans (6) 6
macular degeneration (6) 6
vascular endothelial growth factor (6) 6
aged (5) 5
eye diseases (5) 5
female (5) 5
genetic structures (5) 5
male (5) 5
aged, 80 and over (4) 4
middle aged (4) 4
adult (3) 3
age (3) 3
care and treatment (3) 3
fluorescein angiography (3) 3
medical imaging (3) 3
patients (3) 3
retina (3) 3
review (3) 3
review article (3) 3
sense organs (3) 3
usage (3) 3
angiogenesis (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
article subject (2) 2
bevacizumab (2) 2
clinical ophthalmology (2) 2
cross-sectional studies (2) 2
diabetic retinopathy (2) 2
diagnosis (2) 2
epidemiology (2) 2
health aspects (2) 2
internal medicine (2) 2
intravitreal injection (2) 2
medicine, research & experimental (2) 2
optical coherence tomography (2) 2
original research (2) 2
photochemotherapy (2) 2
ranibizumab - therapeutic use (2) 2
receptors, vascular endothelial growth factor - therapeutic use (2) 2
recombinant fusion proteins - therapeutic use (2) 2
research (2) 2
research & experimental medicine (2) 2
retinal diseases (2) 2
retinal vein occlusion (2) 2
ss-oct (2) 2
studies (2) 2
swept source oct (2) 2
tomography, optical coherence (2) 2
tomography, optical coherence - methods (2) 2
visual acuity (2) 2
acuity (1) 1
adolescent (1) 1
age macular degeneration (1) 1
aging - pathology (1) 1
amd (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antioxidants (1) 1
apoptosis (1) 1
arteries (1) 1
beaver dam eye (1) 1
best‐corrected visual acuity (1) 1
beta-carotene (1) 1
bevacizumab - pharmacology (1) 1
bevacizumab - therapeutic use (1) 1
biomarkers (1) 1
blue mountains eye (1) 1
brachytherapy (1) 1
branch retinal artery occlusion (1) 1
calcification (1) 1
calcinosis - diagnosis (1) 1
cancer (1) 1
capillary permeability - physiology (1) 1
carotid arteries (1) 1
case report (1) 1
case studies (1) 1
central retinal artery occlusion (1) 1
choroid (1) 1
choroid - pathology (1) 1
choroid diseases - diagnosis (1) 1
choroid neoplasms - diagnosis (1) 1
choroid neoplasms - therapy (1) 1
choroidal neovascularization - diagnosis (1) 1
choroidal thickness (1) 1
clinical trials as topic (1) 1
clinical-trial (1) 1
coherence (1) 1
complications and side effects (1) 1
deoxyribonucleic acid--dna (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diabetic macular edema (1) 1
diabetic retinopathy - complications (1) 1
diabetic retinopathy - drug therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Retina (Philadelphia, Pa.), ISSN 0275-004X, 10/2019, Volume 39, Issue 10, pp. 1889 - 1895
Journal Article
Drugs & aging, ISSN 1170-229X, 10/2015, Volume 32, Issue 10, pp. 797 - 807
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - metabolism | Ranibizumab - adverse effects | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Wet Macular Degeneration - metabolism | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Recombinant Fusion Proteins - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Wet Macular Degeneration - pathology | Treatment Outcome | Clinical Trials as Topic | Aging - pathology | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - drug therapy | Ranibizumab - administration & dosage | Aged | Receptors, Vascular Endothelial Growth Factor - adverse effects | Macular degeneration | Care and treatment | Dosage and administration | Health aspects | Vascular endothelial growth factor | Index Medicus | Review
Journal Article
Journal Article